LANATUS PHARMA CONSULTANCY SERVICES LTDActive

Company number 12728409Private limited companyIncorporated 2020
⚠ Accounts overdue. The next accounts were due on 30 Apr 2026 and had not been filed when the register was last updated.
⚠ Confirmation statement overdue. It was due on 21 Jul 2026.

Key figures

£5,581-63.5%
Net assets 2023/24
-13.3%
Average annual change 2020/21–2023/24
05 k10 k15 k20 k2020/212021/222022/232023/24

Ratios

2023/24
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 k20 k2020/212021/222022/232023/24
Filed accounts2020/21–2023/24
2020/212021/222022/232023/24
Turnover——94,81478,197
Profit for the year——66,60913,495
Cash at bank and in hand14,145———
Total assets14,1457,79619,1538,956
Total liabilities—6,5673,8703,375
Net assets / total equity8,5591,23015,2835,581
Average number of employees1001
Average pay (per year)———49,364

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: LANATUS PHARMA CONSULTANCY SERVICES LTD

Company

LANATUS PHARMA CONSULTANCY SERVICES LTD is a private limited company registered with Companies House under company number 12728409. It was incorporated on 8 Jul 2020. Its status is active. The registered office is in Wandsworth (SW11). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2023/24 (period ending 31 Jul 2024); the company files micro-entity accounts. Turnover was £78,197. Profit for the year was £13,495. Net assets were £5,581, down 63.5% on the previous year. Total assets were £8,956 and total liabilities £3,375. The company had an average of 1 employee. Figures are available for 4 financial years (2020/21–2023/24).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Apr 2026. The next confirmation statement is due by 21 Jul 2026.